Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-014766
Filing Date
2018-01-19
Accepted
2018-01-19 16:23:03
Documents
7
Effectiveness Date
2018-01-19

Document Format Files

Seq Description Document Type Size
1 DEFA14A d474587ddefa14a.htm DEFA14A 34532
2 GRAPHIC g510622g05e15.jpg GRAPHIC 23408
3 GRAPHIC g510622g16q56.jpg GRAPHIC 13701
4 GRAPHIC g510622g27c51.jpg GRAPHIC 31353
5 GRAPHIC g510622g62d05.jpg GRAPHIC 24728
6 GRAPHIC g510622g76c99.jpg GRAPHIC 32714
7 GRAPHIC g510622g87n84.jpg GRAPHIC 13084
  Complete submission text file 0001193125-18-014766.txt   227397
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-35839 | Film No.: 18537579
SIC: 2834 Pharmaceutical Preparations